ROSSARI / NSE / Chemical Manufacturing
Rossari Biotech
1Y Price Trend
Key Information
Recommendations
RatingBuy
Target High767.55
Target Low372.9
Target Mean1.8
Target Median0
Risk Metrics
Overall RiskBalanced risk
Board Risk40.4
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Indian stocks gained on May 13, ending a four-day decline, with the Nifty 50 rising 0.14%. Analysts predict a positive market start today and recommend buying shares from companies like NLC India and Rossari Biotech amid improving global conditions.
Supreet Chemicals Limited has filed its Draft Red Herring Prospectus with SEBI for an IPO of up to ₹ 499 crore. Proceeds will fund a new manufacturing facility and repay borrowings, with strong investor interest expected due to the company's robust growth and market position.
Q1 results today: At least nine companies including Kotak Mahindra Bank, YES Bank, JK Cement, Poonawala Fincorp, RBL Bank, Newton Technologies, Can Fin Homes, ICRA, Rossari Biotech will declare their Fy25 earnings on July 20.
Rossari Biotech shares have quoted at an average P/E of around 45x in the last four years and 32x FY24 earnings. The brokerage firm reckons that a consistently better performance would be seen on capacity expansion, product launches and better margins.
Q1 results today: 18 companies that would be announcing Q1 results 2023 on Saturday include Rossari Biotech, Sonata Software, IDFC First Bank, NTPC, MCX, D-Link India, etc
© SharekeyX | Rusaka Technologies 2024-2026

